REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot142510.32687/1561-5936-2022-26-2-147-154Original ArticlePharmacoeconomical analysis of treatment regimens for diabetes mellitus in outpatient settingsKrylovaO. V.olgakrylova70@mail.ruLitvinovaT. M.-DenisovaM. N.-MarkovaT. M.-I. M. Sechenov First Moscow State Medical University (Sechenov University)Pirogov Russian National Research Medical University1512202226214715420062022Copyright © 2022,2022The article presents a pharmacoeconomical study of treatment regimens for type 1 and type 2 diabetes mellitus in outpatient settings. Direct medical, direct non-medical and indirect costs were analyzed. Within the framework of direct medical costs, the cost of drug therapy, the cost of laboratory and instrumental research methods, the cost of providing services by medical professionals were considered. To calculate direct medical costs, we analyzed education in diabetes schools, undergoing sanatorium treatment. Indirect costs included payments of disability benefits, payments on temporary disability sheets. The data obtained formed the basis for the analysis of the «cost of the disease».pharmacoeconomical analysisdisease costtype 1 diabetes mellitustype 2 diabetes mellitusфармакоэкономический анализстоимость болезнисахарный диабет 1-го типасахарный диабет 2-го типа[Дедов И. И., Шестакова М. В., Викулова О. К. и др. Эпидемиологические характеристики сахарного диабета в Российской Федерации: клинико-статистический анализ по данным регистра сахарного диабета на 01.01.2021 // Сахарный диабет. 2021. № 3. С. 204-221. DOI: 10.14341/DM12759]